Cargando…
Genetics of Lafora progressive myoclonic epilepsy: current perspectives
Lafora disease (LD) is a fatal neurodegenerative disorder caused by loss-of-function mutations in either laforin glycogen phosphatase gene (EPM2A) or malin E3 ubiquitin ligase gene (NHLRC1). LD is associated with gradual accumulation of Lafora bodies (LBs). LBs are aggregates of polyglucosan, a long...
Autores principales: | Kecmanović, Miljana, Keckarević-Marković, Milica, Keckarević, Dušan, Stevanović, Galina, Jović, Nebojša, Romac, Stanka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859416/ https://www.ncbi.nlm.nih.gov/pubmed/27194917 http://dx.doi.org/10.2147/TACG.S57890 |
Ejemplares similares
-
Sustained seizure remission on perampanel in progressive myoclonic epilepsy (Lafora disease)()
por: Schorlemmer, Kathrin, et al.
Publicado: (2013) -
Progressive Myoclonic Epilepsy Due to Lafora Body Disease with a Novel Mutation
por: Israni, Anil V., et al.
Publicado: (2018) -
Lack of p62 Impairs Glycogen Aggregation and Exacerbates Pathology in a Mouse Model of Myoclonic Epilepsy of Lafora
por: Pellegrini, Pasquale, et al.
Publicado: (2021) -
PTG Depletion Removes Lafora Bodies and Rescues the Fatal Epilepsy of Lafora Disease
por: Turnbull, Julie, et al.
Publicado: (2011) -
Progressive myoclonic epilepsy with Fanconi syndrome
por: Seaby, Eleanor G, et al.
Publicado: (2016)